The team engineered genes to code for the RING constructs and delivered them to mice using an adenovirus vector, commonly ...
D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...
Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...
the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector ...
Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...
The company said the single-arm multicenter Phase II trial may support accelerated approval for the RP-A501 gene therapy in the US.
Researchers at the Karolinska Institute continue to investigate whether gene therapy can improve vision in people with ...
Delve into Vironexis' launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.
It can be used to test for unwanted, potentially dangerous agents, including contamination, gene expression changes, vector and host genome integrity and sample identity and purity. Biopharma ...
A team of researchers report findings from a Phase I/II gene therapy clinical trial for patients with Leber congenital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback